Ferghana Partners Group
  • About
    • Firm
    • Team
  • Expertise
    • Acquisitions
    • Divestments
    • Financings
    • Partnering
  • Sector Focus
    • Biotechnology
    • Diagnostics/Tools
    • Medical Devices
    • OTC Drugs
    • Pharmaceuticals
    • Specialty Chemicals
  • Transactions
  • Media
  • Contact
Blog
Home Press Release AFT Pharmaceuticals

AFT Pharmaceuticals

  • May 9, 2016
  • ferghanaadmin
  • Press Release

“Maxigesic® Partnered in 69 Countries”

Related Posts

Chemical Marker Reporter

"SCHERING AG; acquired rights for Refludan"

FPG Press Release

"Ferghana Partners Advised Schering AG on Refludan Transaction with Pharmion"

Stem Cell Business News

"Stem Cell Sector Needs a Viable Product to Spark Investor Interest"

Recent Posts
  • Clinical Orthopedic Society – Abstract #58
  • Clinical Orthopedic Society – Abstract #57
  • Celularity
  • Mina Therapeutics
  • Excision BioTherapeutics
Recent Comments
    Archives
    • May 2023
    • January 2018
    • November 2017
    • September 2017
    • August 2017
    • May 2017
    • May 2016
    • April 2016
    • October 2015
    Categories
    • Press Release
    • Publication
    Meta
    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org
    • Anteo Diagnostics
    • AFT Pharmaceuticals
    I am the footer call-to-action block, here you can add some relevant/important information about your company or product. I can be disabled in the theme options.
    Get In Touch
    • Site Map
    • Contact
    • Home
    COPYRIGHT 2018 | ALL RIGHTS RESERVED | View our Privacy policy.